Humanigen, Inc., has dosed the first COVID-19 patient in its Phase III study for lenzilumab, its Humaneered anti-human granulocyte macrophage-colony...
Read more
Bioclinica has introduced a specialized program for the adjudication of adverse events that could result from COVID-19 infection. Bioclinica’s new...
Read more
Pfizer Inc. and BioNTech SE announced that the first participants have been dosed in the U.S. in the Phase 1/2...
Read more
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced...
Read more
Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial...
Read more
CytoSMART Technologies is to donate 100 mini live-cell imaging systems to researchers in high containment labs worldwide. Labs working to combat COVID-19 will...
Read more
Germany's vaccines regulator approved live human testing of a potential vaccine against COVID-19 developed by German biotech company BioNTech, the...
Read more
Researchers at Queen’s University Belfast are leading a UK-wide clinical trial, offering an innovative cell therapy treatment for COVID-19 patients...
Read more
As the COVID-19 pandemic continues globally, biopharma companies have rushed to develop vaccines, new drugs and repurpose old drugs in...
Read more
Almac Clinical Technologies, a member of the Almac Group, has announced the expedited deployment and support of multiple Interactive Response...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
